• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
Home
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Pharma
    • Asia
    • Drug Delivery
    • Executives
    • Clinical Data
  • Vaccines
  • Special Reports
  • Trending
    • COVID-19
    • Cell & Gene Therapy
  • Podcasts
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
  • Subscribe
Search Icon
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Pharma
    • Asia
    • Drug Delivery
    • Executives
    • Clinical Data
  • Vaccines
  • Special Reports
  • Trending
    • COVID-19
    • Cell & Gene Therapy
  • Podcasts
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events

Marketing

image-icon
Marketing

Top 10 most anticipated drug launches of 2023

For the third year in a row, Evaluate Vantage’s most hotly tipped drug approval when it comes to future sales potential is an Alzheimer’s therapy.
Ben Adams , Zoey Becker , Kevin Dunleavy Feb 6, 2023 3:00am

J&J breaks out the blue jacket for prostate cancer awareness

Feb 7, 2023 7:35am

Endo launches new DTC campaign to set men straight

Feb 6, 2023 10:17am

AbbVie top TV drug ad spender in January

Feb 6, 2023 9:45am

Bayer aspirin campaign links stress of sports to heart health

Feb 6, 2023 8:00am

Publicis wants to help people who are working with cancer

Feb 6, 2023 7:40am
More News

Gilead's Trodelvy takes home key breast cancer nod

Feb 3, 2023 11:12am

Salix's first streaming TV ad for Relistor introduces MU-MAN

Feb 3, 2023 9:05am

GSK flu campaign appeals to home's chief health officer—mom

Feb 2, 2023 6:55am

Novartis delays Pluvicto filing after FDA requests more data

Feb 1, 2023 11:19am
See more
Home
  • Connect
    • The Team
    • Advertise
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2023 Questex LLC All rights reserved.
Terms of use
Privacy Policy